|Articles|July 1, 2018
- Pharmaceutical Executive-07-01-2018
- Volume 38
- Issue 7
Pharmaceutical Executive, July 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Opioid Litigation: Evading the Widening Crosshairsabout 8 years ago
Patient & Customer-Centric Commercializationabout 8 years ago
Compliance: The Critical Cog in Pharma Machineabout 8 years ago
Gaining Ground with Stem Cells: Gil Van Bokkelen, Athersysabout 8 years ago
A Seat at the Strategy Tableabout 8 years ago
Regulatory Innovation Generates Breakthroughsabout 8 years ago
China’s Biopharma Rise: Opportunities and ThreatsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5